Authors' reply

Affiliations

¹ Department of Inter-Organ Communication Research, Niigata University Graduate School of Medical and Dental Sciences, Asahimachi 1-757, Chuo-ku, Niigata, 951-8510, Japan. minakowa@med.niigata-u.ac.jp.
² Department of Inter-Organ Communication Research, Niigata University Graduate School of Medical and Dental Sciences, Asahimachi 1-757, Chuo-ku, Niigata, 951-8510, Japan.
³ Sado General Hospital, Niigata, Japan.
⁴ Division of Orthopedic Surgery, Niigata University Graduate School of Medical and Dental Science, Niigata, Japan.
⁵ Division of Preventive Medicine, Niigata University Graduate School of Medical and Dental Sciences, Niigata, Japan.
⁶ Department of Neurology, Brain Research Institute, Niigata University, Niigata, Japan.
⁷ Division of Clinical Nephrology and Rheumatology, Niigata University Graduate School of Medical and Dental Sciences, Niigata, Japan.

Comment

Minako Wakasugi et al. J Bone Miner Metab. 2022 May.

. 2022 May;40(3):537-538.

doi: 10.1007/s00774-022-01315-9. Epub 2022 Feb 20.

¹ Department of Inter-Organ Communication Research, Niigata University Graduate School of Medical and Dental Sciences, Asahimachi 1-757, Chuo-ku, Niigata, 951-8510, Japan. minakowa@med.niigata-u.ac.jp.
² Department of Inter-Organ Communication Research, Niigata University Graduate School of Medical and Dental Sciences, Asahimachi 1-757, Chuo-ku, Niigata, 951-8510, Japan.
³ Sado General Hospital, Niigata, Japan.
⁴ Division of Orthopedic Surgery, Niigata University Graduate School of Medical and Dental Science, Niigata, Japan.
⁵ Division of Preventive Medicine, Niigata University Graduate School of Medical and Dental Sciences, Niigata, Japan.
⁶ Department of Neurology, Brain Research Institute, Niigata University, Niigata, Japan.
⁷ Division of Clinical Nephrology and Rheumatology, Niigata University Graduate School of Medical and Dental Sciences, Niigata, Japan.

No abstract available

Comment on

Polypharmacy and bone fracture risk.
Lai SW, Hwang BF, Liu CS, Liao KF. Lai SW, et al. J Bone Miner Metab. 2022 May;40(3):535-536. doi: 10.1007/s00774-021-01307-1. Epub 2022 Feb 2. J Bone Miner Metab. 2022. PMID: 35107607 No abstract available.

1. Lai SW, Hwang BF, Liu CS, Liao KF (2021) Polypharmacy and bone fracture risk. J Bone Miner Metab
1. Wakasugi M, Yokoseki A, Wada M, Momotsu T, Sato K et al (2021) Polypharmacy, chronic kidney disease, and incident fragility fracture: a prospective cohort study. J Bone Miner Metab. https://doi.org/10.1007/s00774-021-01272-9 (Epub ahead of print) - DOI - PubMed
1. Wakasugi M, Kazama JJ, Wada A, Hamano T, Masakane I, Narita I (2020) Long-term excess mortality after hip fracture in hemodialysis patients: a nationwide cohort study in Japan. J Bone Miner Metab 38:718–729 - DOI
1. Sakabe T, Imai R, Murata H, Fujioka M, Iwamoto N, Ono T, Kubo T (2006) Life expectancy and functional prognosis after femoral neck fractures in hemodialysis patients. J Orthop Trauma 20:330–336 - DOI
1. Komorita Y, Ohkuma T, Iwase M, Fujii H, Oku Y, Higashi T, Oshiro A, Sakamoto W, Yoshinari M, Nakamura U, Kitazono T (2021) Polypharmacy and bone fracture risk in patients with type 2 diabetes: the Fukuoka diabetes registry. Diabetes Res Clin Pract 181:109097. https://doi.org/10.1016/j.diabres.2021.109097 - DOI - PubMed